Literature DB >> 21659752

Epidemiology of diabetic nephropathy.

Anne T Reutens, Robert C Atkins.   

Abstract

Diabetic nephropathy affects approximately one third of people with type 1 or type 2 diabetes mellitus. Risk factors affecting progression of kidney disease include baseline albumin excretion, age, glycemic control, blood pressure, serum cholesterol and use of renin-angiotensin system blockers. As the total number of people with diabetes is projected to increase substantially to 2050, the prevalence of diabetic nephropathy will rise dramatically, with concomitant increase in associated cardiovascular mortality and endstage renal disease. This will produce significant social and economic ramifications, particularly in the developing world.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21659752     DOI: 10.1159/000324934

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  66 in total

1.  Serum 25-hydroxyvitamin D level and diabetic nephropathy in patients with type 2 diabetes mellitus.

Authors:  Yan Peng; Liu-Juan Li
Journal:  Int Urol Nephrol       Date:  2015-04-24       Impact factor: 2.370

2.  Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.

Authors:  Brenda I Luna-Antonio; Rafael Rodriguez-Muñoz; Carmen Namorado-Tonix; Paula Vergara; Jose Segovia; Jose L Reyes
Journal:  Histochem Cell Biol       Date:  2017-03-18       Impact factor: 4.304

Review 3.  Biotransformation effect of Bombyx Mori L. may play an important role in treating diabetic nephropathy.

Authors:  Lei Zhang; Yin Li; Xin-Feng Guo; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2015-12-19       Impact factor: 1.978

4.  Over-expression of muscle glycogen synthase in human diabetic nephropathy.

Authors:  Rodrigo Gatica; Romina Bertinat; Pamela Silva; Pamela Kairath; Felipe Slebe; Fabián Pardo; María J Ramírez; Juan C Slebe; José M Campistol; Francisco Nualart; Carme Caelles; Alejandro J Yáñez
Journal:  Histochem Cell Biol       Date:  2014-11-05       Impact factor: 4.304

Review 5.  Diabetic nephropathy: diagnosis and treatment.

Authors:  Daniel Fineberg; Karin A M Jandeleit-Dahm; Mark E Cooper
Journal:  Nat Rev Endocrinol       Date:  2013-10-08       Impact factor: 43.330

6.  Mannose-Binding Lectin and Diabetic Nephropathy in Type 1 Diabetes.

Authors:  Shi-Qi Zhao; Zhao Hu
Journal:  J Clin Lab Anal       Date:  2015-07-24       Impact factor: 2.352

7.  Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.

Authors:  Li Qin Tang; Feng Ling Wang; Ling Na Zhu; Fei Lv; Sheng Liu; Shan Tang Zhang
Journal:  Mol Biol Rep       Date:  2012-12-25       Impact factor: 2.316

8.  Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats.

Authors:  Li Zhang; Kanghua Li; Xiangfei Liu; Diangeng Li; Congjuan Luo; Bo Fu; Shaoyuan Cui; Fei Zhu; Robert Chunhua Zhao; Xiangmei Chen
Journal:  Stem Cells Dev       Date:  2013-08-21       Impact factor: 3.272

9.  Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.

Authors:  Feng Ling Wang; Li Qin Tang; Feng Yang; Ling Na Zhu; Ming Cai; Wei Wei
Journal:  Mol Biol Rep       Date:  2012-11-30       Impact factor: 2.316

10.  Noninvasive evaluation of diabetic patients with high fasting blood glucose using DWI and BOLD MRI.

Authors:  Shuang-Shuang Zheng; Yue-Ming He; Jie Lu
Journal:  Abdom Radiol (NY)       Date:  2020-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.